FDA 483 - Brien E. Pierpont, M.D. - February 26, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Advance Medical Research, Inc. in Saint Petersburg, FL, a clinical investigator, revealed significant deviations from the investigational plan. The firm failed to conduct investigations in accordance with the signed statement of investigator and investigational plan, leading to issues with subject eligibility, incorrect treatment stratification, and missing laboratory samples. These findings indicate a failure to adhere to study protocols and regulatory requirements.
ID · 7497bae3-afaf-4730-832c-6a17739e4ec0